Alpha-Glutamyltryptophan Uses, Dosage, Side Effects and more
Alpha-Glutamyltryptophan is a synthetic dipeptide immunomodulator in development for the treatment of chronic hepatitis C viral infection. Alpha-Glutamyltryptophan was originally developed to treat severe infectious disease in Russia (where it is a registered pharmaceutical), and was extensively studied in cancer clinical trials in the United States before being acquired by Implicit Bioscience in 2005. Alpha-Glutamyltryptophan works as a regulator of the body's immune response, is being given by intranasal administration to patients with chronic hepatitis C viral infection.
Alpha-Glutamyltryptophan regulates the body's innate immune response to defeat invading germs and cancer cells. It may control or reverse the suppression of the immune system which the hepatitis virus uses to defeat our normally healthy defenses.
| Trade Name | Alpha-Glutamyltryptophan |
| Generic | Oglufanide |
| Oglufanide Other Names | alpha-Glutamyltryptophan, Glutamyltryptophan, Oglufanide |
| Type | |
| Formula | C16H19N3O5 |
| Weight | Average: 333.344 Monoisotopic: 333.132470724 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hepatitis (viral, C).
